NASDAQ : DNLI

Denali Therapeutics Inc. — Stock Grades

$23.02 USD

-$1.33 (-5.46%)

Volume
1.21M
Average Volume
1.9M
Market Capitalization
$3.65B
P/E Ratio
-7.99
Dividend Yield
0.00%
Price Target
$36.00
Year High
$27.30
Year Low
$12.58
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$9.28
DNLI Stock Grades
Date Grading Company Previous Grade New Grade Action
2026-07-23 Morgan Stanley Overweight Overweight Maintain
2026-07-16 Deutsche Bank Buy Buy Maintain
2026-05-26 Morgan Stanley Overweight Overweight Maintain
2026-05-14 Morgan Stanley Overweight Overweight Maintain
2026-05-11 BTIG Buy Buy Maintain
2026-05-08 Wedbush Outperform Outperform Maintain
2026-04-22 Leerink Partners Outperform Outperform Maintain
2026-04-07 Baird Outperform Outperform Maintain
2026-03-26 Goldman Sachs Buy Buy Maintain
2026-03-26 Morgan Stanley Overweight Overweight Maintain
2026-03-26 Stifel Buy Buy Maintain
2026-03-26 Baird Outperform Outperform Maintain
2026-03-26 HC Wainwright & Co. Buy Buy Maintain
2026-03-25 BTIG Buy Buy Maintain
2026-03-02 BTIG Buy Buy Maintain
2026-02-06 BTIG Buy Buy Maintain